Maria De La Paz Bettinotti

Medicine & Life Sciences

1. Alleles 100%
2. HLA-A Antigens 67%
3. Epitopes 61%
4. HLA Antigens 54%
5. Melanoma 45%
6. Haplotypes 43%
7. T-Lymphocytes 42%
8. Melanoma-Specific Antigens 40%
9. Antigens 40%
10. Peptides 39%
11. Neutrophils 38%
12. HLA-A*02:01 antigen 33%
13. Genes 33%
14. Polycythemia Vera 32%
15. Polymerase Chain Reaction 31%
16. Transplantation 29%
17. HLA-DRB1 Chains 27%
18. Graft vs Host Disease 27%
19. Oligonucleotide Probes 25%
20. Cytomegalovirus 24%
21. Cyclophosphamide 22%
22. DNA 22%
23. Transplants 21%
24. Tissue Donors 20%
25. Antibodies 20%
26. Histocompatibility Testing 20%
27. Tumor-Infiltrating Lymphocytes 19%
28. High-Throughput Nucleotide Sequencing 19%
29. Exons 19%
30. Peripheral Blood Stem Cell Transplantation 19%
31. MART-1 Antigen 18%
32. Haploidentical Transplantation 18%
33. HLA-DRB5 Chains 18%
34. HLA-B Antigens 18%
35. Vaccination 17%
36. Hematopoietic Stem Cell Transplantation 17%
37. Cytokine Release Syndrome 17%
38. Pseudogenes 17%
39. T-Lymphocyte Epitopes 16%
40. Allografts 16%
41. Transplant Recipients 16%
42. Fibroblast Growth Factor 5 16%
43. Linkage Disequilibrium 16%
44. Immunogenetics 16%
45. HLA-A*33 antigen 15%
46. Juvenile pauciarticular chronic arthritis 15%
47. HLA-A2 Antigen 15%
48. Systemic Lupus Erythematosus 15%
49. Neoplasms 14%